IC
AGTC

Ikarian Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Ikarian Capital’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-412,293
Closed -$440K – 242
2022
Q1 		$440K Buy
412,293
+21,899
+6% +$39.8K 0.13% 141
2021
Q4 		$742K Hold
390,394
– – 0.21% 112
2021
Q3 		$1.18M Sell
390,394
-25,490
-6% -$90.8K 0.27% 152
2021
Q2 		$1.63M Hold
415,884
– – 0.29% 142
2021
Q1 		$2.11M Sell
415,884
-130,000
-24% -$674K 0.31% 198
2020
Q4 		$2.23M Hold
545,884
– – 0.41% 148
2020
Q3 		$2.65M Hold
545,884
– – 0.74% 97
2020
Q2 		$3.02M Hold
545,884
– – 0.92% 93
2020
Q1 		$1.79M Buy
545,884
+345,000
+172% +$1.82M 0.67% 100
2019
Q4 		$908K Buy
+200,884
New +$635K 0.84% 82

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return